Yokohama City University succeeded in detecting antiviral antibodies in the serum of patients with COVID-19.

Yokohama City University (Chairman Yoshiyuki Futami). Installer: Yokohama City) is promoting a wide range of collaborations, including the development of human resources, the provision of medical care, and the resolution of urban issues and issues closely related to civil life, while sharing medium-term goals.
As the number of patients with COVID-19 infections increases, a research team at Yokohama City University has succeeded in detecting viral antibodies that lead to a new diagnostic method.
The method used to detect viral antibodies is a revolutionary one that can be determined in a short time without using a special device, and because it is a test by collecting blood, the risk of secondary infection is low.
In the future, we will aim for practical use by verifying with a large number of samples, establishing diagnostic methods and developing diagnostic kits, but it is expected to have a significant effect on simplification and speeding up diagnosis of COVID-19 infection.